Astellas to Make US$13 Million Investment in Boston Area to Support Startups

October 3, 2019
Astellas Pharma said on October 1 that it will invest a total of nearly US$13 million in two innovation incubators operated by LabCentral, a Boston-based laboratory facility for next-generation biotech startups. LabCentral, a non-profit organization, offers shared laboratory space and...read more